《大行報告》摩通上調攜程(TCOM.US)目標價至27美元 評級「中性」
摩根大通發表研究報告,將攜程(09961.HK)(TCOM.US)的美股目標價從23美元上調至27美元,對應2023年預測市盈率約22倍,指出攜程的股價在過去一個月累升30%,跑嬴同期科技股指數表現,相信是由於6月初起國內旅遊健康復甦所致。
惟摩通表示,受目前各地疫情影響,下半年旅遊業前景未見,加上現時出境航班減少,考慮到出境業務對攜程貢獻較大,預期市場復甦步伐將影響未來6至12個月股價表現。
該行表示,市場估計明年出境旅行量將恢復2019年同期的30%水平,而該行預測僅恢復至20%,指出出境旅遊的恢復情況很大程度上取決於航班供應,目前仍未見起色,重申「中性」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.